Acute Kidney Injury (AKI)

Mission

The Acute Kidney Injury (AKI) Clinical Domain Team aims to investigate risk factors associated with kidney injury and recovery, as well as use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in kidney disease. Their research involves the assessment of risk factors, predictors, duration, dialysis need and timing, clinical measures, and interventions for COVID-19-related complications of the kidney. The team also collaborates with other nephrology domain experts.

 

 

First Time Users: To get started with N3C and gain access to the N3C Data Enclave, please view the Researcher Essentials webpage.
For Questions or Comments: Please access the N3C Support Desk and click on "Request Domain Team Support".

Google Group Email
n3c-tt-akiarbace@googlegroups.com

Leadership

Sandeep Mallipattu Headshot
Sandeep Mallipattu, MD, FASN

Stony Brook Medicine

Richard Moffitt Headshot

Stony Brook Medicine

Farrukh Koraishy, MD, PhD, FASN

Stony Brook University Hospital